Abstract
AbstractImpaired reproductive health is a worldwide problem that affects the psychological well-being of a society. Despite the technological developments to treat infertility, the global infertility rate is increasing significantly. Many infertility conditions are currently treated using various advanced clinical approaches such as intrauterine semination (IUI), in vitro fertilization (IVF), and intracytoplasmic injection (ICSI). Nonetheless, clinical management of some conditions such as dysfunctional endometrium, premature ovarian failure, and ovarian physiological aging still pose significant challenges. Stem cells based therapeutic strategies have a long-standing history to treat many infertility conditions, but ethical restrictions do not allow the broad-scale utilization of adult mesenchymal stromal/stem cells (MSCs). Easily accessible, placental derived or amniotic stem cells present an invaluable alternative source of non-immunogenic and non-tumorigenic stem cells that possess multilineage potential. Given these characteristics, placental or amniotic stem cells (ASCs) have been investigated for therapeutic purposes to address infertility in the last decade. This study aims to summarize the current standing and progress of human amniotic epithelial stem cells (hAECs), amniotic mesenchymal stem cells (hAMSCs), and amniotic fluid stem cells (hAFSCs) in the field of reproductive medicine. The therapeutic potential of these cells to restore or enhance normal ovarian function and pregnancy outcomes are highlighted in this study.
Funder
Ministry of Public health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology
Reference46 articles.
1. Hui S, Hui G, Ting-Ting J, Yu-Ting ZS, Yu-Hong Z, Wu Q-J. Global, regional, and national prevalence and disability-adjusted life- years for infertility in 195 countries and territories, 1990–2017: results from a global burden of disease study, 2017. Aging. 2019;11(3):10952–71.
2. Strug M, Aghajanova L. Making more womb: Clinical perspectives supporting the development and utilization of mesenchymal stem cell therapy for endometrial regeneration and infertility. J Personal Med. 2021;11(12):1364. https://doi.org/10.3390/jpm11121364.
3. Naeem A, Gupta N, Arzoo N, Naeem U, Khan MJ, Choudhry MU, Cui W, Albanese C. A survey and critical evaluation of isolation, culture, and cryopreservation methods of human amniotic epithelial cells. Cell Cycle. 2022;21(7):655–73.
4. Lai D, Wang F, Chen Y, Wang L, Wang Y, Cheng W. Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility. BMC Dev Biol. 2013;13(1):34. https://doi.org/10.1186/1471-213X-13-34.
5. Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci. 2003;100(20):11457–62.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献